SUMO1 anticorps (N-Term)
Aperçu rapide pour SUMO1 anticorps (N-Term) (ABIN207555)
Antigène
Voir toutes SUMO1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Synthetic peptide corresponding to N-terminal residues of SUMO1 (Small ubiquitin-related modifier 1 precursor)
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from human SUMO1.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
-
Autre désignation
- SUMO1 / SMT3
-
Sujet
-
Name/Gene ID: SUMO1
Synonyms: SUMO1, GAP modifying protein 1, GMP1, OFC10, Sentrin, SMT3 homolog 3, SMT3C, SMT3H3, SUMO-1, Ubiquitin-like protein UBL1, PIC1, Ubiquitin-like 1 (sentrin), UBL1, DAP1, GAP-modifying protein 1, Ubiquitin-like protein SMT3C -
ID gène
- 7341
-
UniProt
- P63165
-
Pathways
- M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
Antigène
-